VivaMed BioPharma is a clinical-stage biopharmaceutical company that develops new chemical entities and repurposed drugs. It serves the healthcare and research sectors by advancing therapies across neurology, pain, psychiatry, pulmonology, and rheumatology through global partnerships and operator-led development.
Subscribe to see Vivamed, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vivamed, Inc. is a biotechnology company headquartered in Santa Monica, United States. Its most recent funding round raised $3M in May 2026. Xcout tracks 3 named people at Vivamed, Inc., including Sepideh Nouri (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3M | — | |
| SEC Form D filing | $110,000 | — | |
| Seed | $3M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Vivamed, Inc.'s closest competitors — see the full list of competitors and alternatives →
Visum Pharma, Inc. is a pharmaceutical company that researches and develops new therapies targeting neurodegeneration and cancer by exploring unexplored biological pathways. The company serves the medical and healthcare sectors by advancing a therapeutic pipeline for these conditions.
Daya CNS is a private biopharmaceutical company headquartered in Saint Peters, Missouri. The company's product pipeline comprises non-opioid treatments and novel antipsychotic drugs designed with fewer side effects.
Neumora Therapeutics is a clinical-stage biopharmaceutical company developing precision medicines for brain diseases, including neuropsychiatric and neurodegenerative disorders. It uses neuroscience, data science, and biomarkers to identify and advance treatments for patients with these conditions.
Synendos Therapeutics is a clinical-stage biopharmaceutical and neuroscience company focused on developing a novel class of small molecules to treat psychiatric and neurological disorders.
Gilgamesh Pharma Inc. is a clinical-stage neuroscience company that develops novel chemical entities to treat psychiatric diseases, aiming to move beyond symptom management toward rapid-acting and durable therapies. The company utilizes an AI-powered discovery platform and medicinal chemistry to create precision therapies targeting conditions such as depression, anxiety, addiction, and schizophrenia.
CiVi Biopharma, Inc. is a privately held biopharmaceutical company headquartered in Chevy Chase, Maryland, founded in 2016 to advance specialized clinical therapeutics.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Vivamed, Inc.? Suggest a correction · Work at Vivamed, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.